Emerging research demonstrates that retatrutide, a novel medication, promises to transform the treatment of excess weight . Distinct from many traditional weight reduction drugs , retatrutide works as both a GLP-1 receiver and a GIP receptor , targeting various pathways involved in appetite control and blood sugar stability . Preliminary patient t